Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IDYA | AZN | AMGN | GILD | BMY |
| Company | Ideaya Biosciences Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 34.29 | 190.67 | 359.82 | 143.16 | 59.35 |
| High | 34.30 | 190.73 | 360.69 | 143.80 | 59.67 |
| Low | 33.22 | 187.56 | 351.11 | 139.23 | 58.81 |
| Latest | 33.26 | 188.96 | 351.55 | 140.55 | 59.24 |
| Change | -1.01 | -2.33 | -9.58 | -3.85 | -0.47 |
| % Change | -2.95% | -1.22% | -2.65% | -2.67% | -0.79% |
| Volume | 352,200 | 862,469 | 1,621,648 | 2,566,375 | 5,230,365 |
| 20-Day Average Volume | 818,848 | 1,848,002 | 2,442,322 | 6,200,083 | 12,007,242 |
| Previous Close | 34.27 | 191.29 | 361.13 | 144.40 | 59.71 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 33.27 | 198.99 | 374.33 | 146.84 | 60.64 |
| 20-Day Raw Stochastic | 54.41% | 8.45% | 0.09% | 11.27% | 16.31% |
| 20-Day Relative Strength | 50.10 | 43.73 | 43.49 | 46.56 | 50.38 |
| Weighted Alpha | +76.06 | +28.69 | +16.23 | +33.95 | +8.78 |
| Today's Opinion | 40% Buy | 56% Buy | 56% Buy | 64% Buy | 80% Buy |
| Previous Opinion | 72% Buy | 56% Buy | 80% Buy | 88% Buy | 80% Buy |
| Last Month's Opinion | 24% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.73% since 03/11/26 | -2.00% since 03/11/26 | -6.87% since 03/11/26 | -3.55% since 03/11/26 | -1.53% since 03/11/26 |
| Low | 32.15 on 03/13/26 | 187.56 on 03/18/26 | 351.65 on 03/18/26 | 139.23 on 03/18/26 | 58.32 on 03/12/26 |
| High | 35.26 on 03/17/26 | 193.96 on 03/17/26 | 375.00 on 03/12/26 | 148.22 on 03/13/26 | 60.81 on 03/17/26 |
| 1-Month | |||||
| %Chg | +8.21% since 02/18/26 | -9.21% since 02/18/26 | -7.38% since 02/18/26 | -7.81% since 02/18/26 | -1.11% since 02/18/26 |
| Low | 30.81 on 02/19/26 | 187.56 on 03/18/26 | 351.65 on 03/18/26 | 139.23 on 03/18/26 | 58.32 on 03/12/26 |
| High | 35.68 on 03/03/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 153.26 on 02/20/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +0.60% since 12/18/25 | +4.54% since 12/18/25 | +8.41% since 12/18/25 | +15.92% since 12/18/25 | +10.75% since 12/18/25 |
| Low | 29.47 on 02/17/26 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 39.28 on 01/07/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +27.61% since 09/18/25 | +22.91% since 09/18/25 | +27.50% since 09/18/25 | +23.93% since 09/18/25 | +29.53% since 09/18/25 |
| Low | 25.27 on 09/19/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 39.28 on 01/07/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,009,386 | 296,673,184 | 194,673,616 | 179,261,184 | 121,597,856 |
| Shares Outstanding, K | 87,814 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 218,710,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -113,700,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 10,880,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -83,270,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.09 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.94 on 02/17/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/05/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.96 | 16.76 | 17.82 | 9.71 |